{
  "question_stem": {
    "en": "A 40-year-old woman comes to the office due to a 6-month history of abdominal cramping and bloating associated with diarrhea. She experiences a strong urge to defecate shortly after meals and passes a small amount of stool and mucus 3 or 4 times daily, after which her cramping resolves. The patient has seen no blood in her stool and has had intermittent mild heartburn. She has had no fevers, chills, or weight loss. Medical history is significant for seasonal allergic rhinitis. Medications include only a multivitamin supplement. Vital signs and physical examination are normal. After a normal laboratory evaluation, the patient is prescribed a trial of loperamide therapy.",
    "zh": "一名40岁女性因腹部绞痛和腹胀6个月前来就诊，伴有腹泻。她在餐后不久就感到强烈的排便冲动，每天排便3或4次，每次排出少量粪便和黏液，之后绞痛缓解。患者的粪便中未见血，并有间歇性轻度烧心。她没有发烧、寒战或体重减轻。病史有季节性过敏性鼻炎。药物治疗仅包括多种维生素补充剂。生命体征和体格检查均正常。在正常的实验室评估后，患者被处方试用洛哌丁胺治疗。"
  },
  "question": {
    "en": "Which of the following is the most likely primary target of this medication?",
    "zh": "以下哪项是该药物最可能的主要靶点？"
  },
  "options": {
    "A": {
      "en": "Enteric secretomotor neurons",
      "zh": "肠神经分泌运动神经元"
    },
    "B": {
      "en": "Enteric serotonin receptors",
      "zh": "肠道5-羟色胺受体"
    },
    "C": {
      "en": "Enterocyte chloride channels",
      "zh": "肠细胞氯离子通道"
    },
    "D": {
      "en": "Intestinal brush border cells",
      "zh": "肠刷状缘细胞"
    },
    "E": {
      "en": "Intestinal luminal bile salts",
      "zh": "肠腔胆汁盐"
    },
    "F": {
      "en": "Spinal mu-opioid receptors",
      "zh": "脊髓μ-阿片受体"
    }
  },
  "correct_answer": "A",
  "explanation": {
    "en": "This patient has chronic abdominal pain that subsides with bowel movements associated with changes in stool frequency and form (eg, diarrhea, mucus). Her normal laboratory evaluation and physical examination with no alarm symptoms (eg, weight loss, rectal bleeding) indicate that her symptoms are likely due to DIARRHEA-PREDOMINANT irritable bowel syndrome (IBS).\n\nFor symptomatic relief of diarrhea in IBS, loperamide can be used. Loperamide is an OPIOID AGONIST that binds mu-opioid receptors on the GASTROINTESTINAL SECRETOMOTOR NEURONS (ie, myenteric plexus, submucosal plexus). Loperamide decreases peristalsis, lengthens intestinal transit times, and reduces intestinal fluid and electrolyte secretions. It does not cross the blood-brain barrier; therefore, CNS effects are minimal (Choice F).\n\nDiphenoxylate-atropine is also used to treat diarrhea. Diphenoxylate also binds to the mu-opioid receptors of the gastrointestinal tract; however, unlike loperamide, diphenoxylate crosses the blood-brain barrier and can produce opiate-like euphoria and physical dependence. Therefore, diphenoxylate is combined with atropine, which produces adverse symptoms (eg, dry mouth, blurry vision, nausea) to prevent use in high doses.\n\n(Choice B) Several types of serotonin receptors are present in myenteric and submucosal neurons of the gastrointestinal tract. Serotonin-3 receptor antagonists (eg, ondansetron, alosetron) exert antiemetic and antidiarrheal effects, whereas serotonin-4 receptor agonists increase colonic motility and attenuate visceral pain.\n\n(Choice C) Lubiprostone activates chloride channels on the apical membranes of enterocytes to increase fluid secretion and intestinal transit. It is used to treat constipation-predominant IBS.\n\n(Choice D) Lactase enzyme replacement is used to treat lactose intolerance and facilitates hydrolysis of lactose to glucose and galactose at the brush border cells of the small intestine.\n\n(Choice E) Cholestyramine and colestipol bind bile salts in the intestinal lumen, thereby decreasing enterohepatic reuptake of bile salts. These agents are used to treat postcholecystectomy diarrhea due to excess bile salt in the colon.\n\nEducational objective:\nLoperamide is an antidiarrheal agent that acts as an agonist of mu-opioid receptors on gastrointestinal secretomotor neurons, resulting in decreased peristalsis, longer intestinal transit times, and reduced intestinal fluid and electrolyte secretions. It does not cross the blood-brain barrier; therefore, CNS effects are minimal.",
    "zh": "该患者有慢性腹痛，伴有排便，且粪便频率和性状发生改变（如腹泻、黏液）。她的实验室评估和体格检查结果正常，无报警症状（如体重减轻、直肠出血），这表明她的症状很可能是由于以腹泻为主的肠易激综合征（IBS）引起的。\n\n为了缓解IBS中的腹泻症状，可以使用洛哌丁胺。洛哌丁胺是一种阿片类激动剂，与胃肠道分泌运动神经元（即肌间神经丛、黏膜下神经丛）上的μ-阿片受体结合。洛哌丁胺可减少肠蠕动，延长肠道转运时间，并减少肠液和电解质分泌。它不能通过血脑屏障；因此，中枢神经系统（CNS）的影响很小（选项F）。\n\n苯乙哌啶-阿托品也用于治疗腹泻。苯乙哌啶也与胃肠道的μ-阿片受体结合；然而，与洛哌丁胺不同的是，苯乙哌啶可以通过血脑屏障，并可能产生类似阿片类药物的欣快感和身体依赖性。因此，苯乙哌啶与阿托品联合使用，阿托品会产生不良症状（如口干、视力模糊、恶心），以防止大剂量使用。\n\n（选项B）胃肠道的肌间神经元和黏膜下神经元中存在几种类型的5-羟色胺受体。5-羟色胺-3受体拮抗剂（如昂丹司琼、阿洛司琼）具有止吐和止泻作用，而5-羟色胺-4受体激动剂可增加结肠蠕动并减轻内脏疼痛。\n\n（选项C）利匹前列腺素可激活肠细胞顶端膜上的氯离子通道，以增加液体分泌和肠道转运。它用于治疗以便秘为主的IBS。\n\n（选项D）乳糖酶替代疗法用于治疗乳糖不耐受症，并促进乳糖在小肠刷状缘细胞处水解为葡萄糖和半乳糖。\n\n（选项E）考来烯胺和考来替泊在肠腔内结合胆汁盐，从而减少胆汁盐的肝肠循环重吸收。这些药物用于治疗因结肠中胆汁盐过多引起的胆囊切除术后腹泻。\n\n教学目标：洛哌丁胺是一种止泻药，可作为胃肠道分泌运动神经元上μ-阿片受体的激动剂，从而减少肠蠕动，延长肠道转运时间，并减少肠液和电解质分泌。它不能通过血脑屏障；因此，中枢神经系统（CNS）的影响很小。"
  },
  "summary": {
    "en": "This question tests knowledge of the mechanism of action of loperamide in treating diarrhea-predominant irritable bowel syndrome (IBS). It assesses understanding of the drug's target receptors and its effects on gastrointestinal motility and secretions.\n\nTo solve this question, recognize the clinical presentation of diarrhea-predominant IBS and recall that loperamide is an opioid agonist that acts on gastrointestinal secretomotor neurons to reduce peristalsis and fluid secretion.",
    "zh": "这个问题测试了对洛哌丁胺治疗以腹泻为主的肠易激综合征（IBS）的作用机制的了解。它评估了对药物靶受体的理解及其对胃肠道蠕动和分泌的影响。\n\n要解决这个问题，需要认识到以腹泻为主的IBS的临床表现，并回忆起洛哌丁胺是一种阿片类激动剂，作用于胃肠道分泌运动神经元，以减少蠕动和液体分泌。"
  },
  "tags": "Irritable bowel syndrome; Diarrhea; Loperamide; Gastrointestinal motility; Opioid receptors; Gastrointestinal secretomotor neurons; Antidiarrheal agents; Gastroenterology",
  "category": "GIT",
  "question_id": "1290",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\GIT 23\\1290",
  "extracted_at": "2025-11-05T14:23:20.983156",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T17:50:56.246863",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}